T 0417/04 (Omeprazole/LEK, TOVARNA FARMACEVTSKIH) of 10.01.2007
- European Case Law Identifier
- ECLI:EP:BA:2007:T041704.20070110
- Date of decision
- 10 January 2007
- Case number
- T 0417/04
- Petition for review of
- -
- Application number
- 99930107.0
- IPC class
- C07D 401/12
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Process of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl-1H-benzimidazole
- Applicant name
- Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov
- Opponent name
- AstraZeneca AB
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 123(3) 1973European Patent Convention Art 54 1973European Patent Convention Art 56 1973European Patent Convention Art 64 1973European Patent Convention Art 69 1973European Patent Convention Art 84 1973European Patent Convention R 71a 1973
- Keywords
- Amendment: supported by the application as filed (yes) - extending the protection (no) - Article 69 EPC not relevant to the assessement to be made under Article 123(3) EPC
Novelty (yes)
Inventive step (yes) - non obvious solution - Catchword
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent with the claim filed with the proprietor's letter dated 8 December 2006 and the description as granted.